Navigation Links
Anne Glover and Sir Michael Stratton to meet the press at The EMBO Meeting 2013 in Amsterdam

HEIDELBERG -- Predisposition to cancer and other diseases, genetic testing, infectious proteins and ubiquitin signalling -- these are some of the topics internationally renowned speakers will tackle at The EMBO Meeting 2013 to be held in Amsterdam, the Netherlands, from 21-24 September 2013.

Sir Michael Stratton, Director of the Wellcome Trust Sanger Institute, Kri Stefnsson, Chief Executive Officer of deCODE Genetics, and Thijn Brummelkamp, Group Leader at the Netherlands Cancer Institute and winner of the 2013 EMBO Gold Medal, will discuss The Future of Cancer Genomics in an exclusive press conference for journalists and science writers from 11-12 am on Monday 23 September.

On the same day, Anne Glover, Chief Scientific Adviser to Jos Manuel Barroso, President of the European Commission, will be talking to journalists in a Meet the Press event at 6.00 pm.

Sessions on epigenetics, vaccines, stem cell signalling and European science policy are also part of the programme for The EMBO Meeting.

The EMBO Meeting first took place in Amsterdam in 2009, when the conference attracted more than 1300 participants from 50 countries. Attendees at this year's meeting will include researchers at all stages of their scientific career. Policy makers, editors, career advisors, journalists, science bloggers and exhibitors from industry will also be attending the conference.

The EMBO Meeting 2013 will offer plenaries and concurrent sessions by first-rate speakers. Media participants will have multiple opportunities to cover news and also gather ideas for future stories:

  • At a keynote lecture at 9:00am on Monday, 23 September, Hans Clevers will discuss the challenges in identifying and targeting tumour stem cells (Lgr5 stem cells in self-renewal and cancer).

  • The Women in Science session features award-winning Australian writer Cordelia Fine, a psychologist with interests in neuroscience and gender. Her latest book, Delusions of gender: The real science behind sex differences, was short-listed for the Victorian Premier's Literary Award for Non-Fiction, the Best Book of Ideas Prize 2011 and the John Llewellyn Rhys Prize 2010.

  • The Special Lecture explores the question Is there life on other planets? Christopher McKay who is Planetary Scientist with the Space Science Division of NASA, will deliver an update about the Mars Curiosity Rover.

  • The role of ubiquitin signalling in cancer is the topic of Vishva Dixit, Vice President of Physiological Chemistry at Genentech, part of the Roche Group, and Adjunct Professor at the University of California, San Francisco.

  • Albert Osterhaus is one of the speakers at the concurrent session on vaccines on Tuesday 24 September from 9-11 am. His team played an important role in the identification of the SARS virus in the Hong Kong outbreak in 2002 and was one of the first to identify human infection with the avian influenza strain H5N1.

  • The full programme is available at Online press registration and more information for journalists is available at: The Abstract Book will be emailed to registered participants and journalists two weeks before the conference starts. Interview opportunities can be arranged prior to the conference or on site, beginning on Saturday evening after the opening address.


Contact: Barry Whyte
European Molecular Biology Organization

Related biology news :

1. Brupbacher Prize goes to cancer researcher Michael Karin
2. Researchers and company from Luxembourg awarded a grant from Michael J. Fox Foundation
3. Michael Barnett of Boston College named Professor of the Year for Massachusetts
4. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
5. AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
6. Carnegie Mellon researchers develop artificial cells to study molecular crowding and gene expression
7. Artifact suppression and analysis of brain activities with EEG signals
8. Pressure cooker on steroids treats human waste
9. A calculator to estimate the likelihood of antidepressant response
10. Observing live gene expression in the body
11. Efficacy of acupressure to relieve migraine nausea presented at International Headache Congress
Post Your Comments:
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology: